Contents

Search


drug interaction(s) of gliptins with sulfonylureas

Drug interactions: - combination of gliptin with sulfonylurea - increases risk for hypoglycemia [1] - absolute risk 12% vs 7% for sulfonylurea alone [1] - decreases risk for hypoglycemia (RR = 0.86) [2]

Properties

DRUGS: gliptin sulfonylurea

References

  1. Salvo F et al Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis. BMJ 2016;353:i2231 PMID: 27142267 Free full text http://www.bmj.com/content/353/bmj.i2231
  2. Hippisley-Cox J, Coupland C Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care. BMJ 2016;352:i1450 PMID: 27029547 http://www.bmj.com/content/352/bmj.i1450 - Montori VM Selecting the right drug treatment for adults with type 2 diabetes. BMJ 2016;352:i1663 PMID: 27029501 http://www.bmj.com/content/352/bmj.i1663